This peak is characterised by relatively higher frequencies of exhausted and suppressive immune subsets and reduced frequencies of activated immune subsets; concurrently, the immune landscape turns “cold”, with reduced numbers of infiltrating CD8+ T cells, rendering tumours refractory to immune-mediated suppression. The gene discussed is CD8A; the disease is neoplasm.